Best TWAS P=9.27e-40 · Best GWAS P=2.03e-53 conditioned to NaN
# | Study | Tissue | Gene | h2 | eQTL R2 | model | # weights | model R2 | model R2 P | eQTL GWAS Z | TWAS Z | TWAS P | Top SNP corr | PP3 | PP4 | joint |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | CommonMind | Brain Pre-frontal Cortex | LOC441454 | 0.05 | 0.01 | lasso | 3 | 0.02 | 1.5e-03 | 10.10 | 9.3 | 1.2e-20 | -0.01 | 0.03 | 0.70 | FALSE |
2 | GTEx | Adipose Subcutaneous | HSD17B3 | 0.21 | 0.01 | enet | 31 | 0.04 | 1.9e-04 | 9.56 | 8.3 | 1.1e-16 | 0.10 | 0.27 | 0.34 | FALSE |
3 | GTEx | Adipose Subcutaneous | ERCC6L2 | 0.14 | 0.14 | lasso | 9 | 0.12 | 7.7e-10 | 6.48 | 6.3 | 3.8e-10 | -0.01 | 1.00 | 0.00 | FALSE |
4 | GTEx | Adipose Visceral Omentum | LINC00476 | 0.34 | 0.30 | lasso | 5 | 0.36 | 2.1e-19 | 5.53 | 5.5 | 3.8e-08 | -0.04 | 1.00 | 0.00 | FALSE |
5 | GTEx | Artery Aorta | ERCC6L2 | 0.26 | 0.20 | lasso | 12 | 0.18 | 4.2e-10 | 6.49 | 6.5 | 7.2e-11 | 0.00 | 1.00 | 0.00 | FALSE |
6 | GTEx | Artery Tibial | HIATL1 | 0.24 | 0.15 | lasso | 7 | 0.17 | 1.7e-13 | -3.11 | 5.5 | 3.0e-08 | -0.01 | 1.00 | 0.00 | FALSE |
7 | GTEx | Artery Tibial | ERCC6L2 | 0.22 | 0.18 | enet | 39 | 0.18 | 5.2e-14 | 6.50 | 5.9 | 3.1e-09 | -0.05 | 1.00 | 0.00 | FALSE |
8 | GTEx | Artery Tibial | RP11-435O5.5 | 0.09 | 0.04 | lasso | 2 | 0.02 | 7.3e-03 | 13.57 | -13.2 | 9.3e-40 | -0.44 | 0.25 | 0.05 | TRUE |
9 | GTEx | Brain Caudate basal ganglia | LINC00476 | 0.50 | 0.42 | lasso | 8 | 0.39 | 3.4e-12 | 5.53 | 5.5 | 4.5e-08 | -0.06 | 0.99 | 0.00 | FALSE |
10 | GTEx | Brain Frontal Cortex BA9 | LINC00476 | 0.27 | 0.14 | lasso | 4 | 0.24 | 5.1e-07 | -3.71 | 5.1 | 2.9e-07 | -0.02 | 0.67 | 0.03 | FALSE |
11 | GTEx | Breast Mammary Tissue | CDC14B | 0.16 | 0.02 | enet | 21 | 0.02 | 3.7e-02 | 12.38 | -10.3 | 5.3e-25 | -0.02 | 0.03 | 0.94 | FALSE |
12 | GTEx | Breast Mammary Tissue | ERCC6L2 | 0.17 | 0.02 | lasso | 4 | 0.03 | 1.2e-02 | 6.50 | 8.5 | 2.2e-17 | -0.03 | 0.28 | 0.03 | TRUE |
13 | GTEx | Breast Mammary Tissue (Female) | C9orf156 | 0.42 | 0.22 | lasso | 10 | 0.23 | 1.5e-07 | -3.99 | -5.9 | 4.6e-09 | 0.01 | 0.05 | 0.89 | FALSE |
14 | GTEx | Cells EBV-transformed lymphocytes | AAED1 | 0.17 | 0.02 | lasso | 3 | 0.04 | 2.4e-02 | 12.26 | 10.7 | 6.1e-27 | 0.01 | 0.03 | 0.64 | FALSE |
15 | GTEx | Cells Transformed fibroblasts | HIATL1 | 0.45 | 0.23 | enet | 50 | 0.33 | 1.6e-25 | -3.24 | 7.1 | 1.3e-12 | 0.00 | 1.00 | 0.00 | TRUE |
16 | GTEx | Cells Transformed fibroblasts | ERCC6L2 | 0.19 | 0.02 | enet | 34 | 0.16 | 4.1e-12 | 6.38 | 7.1 | 1.2e-12 | 0.02 | 0.98 | 0.00 | FALSE |
17 | GTEx | Cells Transformed fibroblasts | RP11-435O5.5 | 0.14 | 0.04 | lasso | 4 | 0.02 | 7.9e-03 | 5.36 | -5.3 | 1.4e-07 | 0.22 | 0.20 | 0.47 | FALSE |
18 | GTEx | Esophagus Mucosa | HIATL1 | 0.19 | 0.16 | enet | 19 | 0.17 | 1.7e-11 | -3.25 | 6.2 | 5.5e-10 | 0.00 | 1.00 | 0.00 | FALSE |
19 | GTEx | Esophagus Muscularis | ERCC6L2 | 0.15 | 0.10 | lasso | 6 | 0.08 | 8.8e-06 | 6.53 | 7.7 | 2.0e-14 | -0.01 | 0.87 | 0.01 | FALSE |
20 | GTEx | Heart Atrial Appendage | ERCC6L2 | 0.16 | 0.05 | enet | 22 | 0.10 | 4.6e-05 | 6.53 | 6.8 | 1.5e-11 | 0.02 | 0.59 | 0.02 | FALSE |
21 | GTEx | Heart Atrial Appendage | RP11-435O5.4 | 0.18 | 0.00 | lasso | 5 | 0.00 | 6.2e-01 | 2.01 | -5.6 | 1.9e-08 | 0.06 | 0.07 | 0.06 | TRUE |
22 | GTEx | Liver | LINC00476 | 0.29 | 0.24 | enet | 11 | 0.27 | 3.2e-08 | 6.00 | 5.2 | 1.7e-07 | -0.03 | 0.87 | 0.01 | FALSE |
23 | GTEx | Liver | PTCH1 | 0.25 | 0.06 | enet | 11 | 0.03 | 4.9e-02 | 15.39 | 12.5 | 5.0e-36 | 0.91 | 0.01 | 0.94 | TRUE |
24 | GTEx | Muscle Skeletal | HIATL1 | 0.15 | 0.04 | enet | 26 | 0.07 | 1.4e-07 | -3.04 | -5.1 | 2.9e-07 | -0.01 | 0.98 | 0.00 | FALSE |
25 | GTEx | Nerve Tibial | HSD17B3 | 0.14 | 0.00 | enet | 20 | 0.00 | 2.4e-01 | 12.14 | 10.1 | 5.7e-24 | 0.03 | 0.04 | 0.69 | FALSE |
26 | GTEx | Nerve Tibial | ZNF367 | 0.10 | 0.05 | lasso | 3 | 0.02 | 7.9e-03 | 12.21 | 11.6 | 5.1e-31 | 0.03 | 0.09 | 0.86 | FALSE |
27 | GTEx | Nerve Tibial | ERCC6L2 | 0.15 | 0.11 | lasso | 6 | 0.10 | 2.2e-07 | 6.51 | 6.5 | 8.6e-11 | 0.03 | 1.00 | 0.00 | TRUE |
28 | GTEx | Pancreas | ERCC6L2 | 0.23 | 0.19 | enet | 18 | 0.22 | 9.7e-10 | 4.25 | 5.2 | 2.4e-07 | -0.02 | 1.00 | 0.00 | FALSE |
29 | GTEx | Skin Sun Exposed Lower leg | ERCC6L2 | 0.21 | 0.19 | lasso | 8 | 0.17 | 4.3e-14 | 6.37 | 6.3 | 2.6e-10 | 0.00 | 1.00 | 0.00 | FALSE |
30 | GTEx | Spleen | PTCH1 | 0.33 | 0.08 | lasso | 8 | 0.18 | 1.9e-05 | -0.61 | 9.9 | 4.1e-23 | 0.64 | 0.04 | 0.81 | FALSE |
31 | GTEx | Testis | HABP4 | 0.19 | 0.22 | lasso | 9 | 0.21 | 1.1e-09 | 12.24 | 12.3 | 1.2e-34 | 0.03 | 0.03 | 0.97 | FALSE |
32 | GTEx | Testis | C9orf3 | 0.15 | 0.00 | enet | 18 | 0.00 | 2.4e-01 | -0.39 | -6.3 | 2.2e-10 | -0.10 | 0.06 | 0.14 | TRUE |
33 | GTEx | Testis | LINC00476 | 0.51 | 0.47 | lasso | 6 | 0.50 | 4.1e-25 | 5.53 | 6.0 | 1.7e-09 | -0.05 | 1.00 | 0.00 | FALSE |
34 | GTEx | Thyroid | CDC14B | 0.15 | 0.10 | lasso | 5 | 0.08 | 5.3e-07 | 12.01 | -11.5 | 8.4e-31 | -0.03 | 0.10 | 0.90 | FALSE |
35 | GTEx | Thyroid | C9orf3 | 0.25 | 0.00 | enet | 45 | 0.02 | 1.8e-02 | -0.71 | -5.1 | 2.9e-07 | -0.06 | 0.08 | 0.03 | TRUE |
36 | GTEx | Thyroid | ERCC6L2 | 0.09 | 0.07 | lasso | 2 | 0.05 | 6.9e-05 | 6.53 | 6.5 | 1.0e-10 | -0.01 | 0.85 | 0.01 | FALSE |
37 | GTEx | Whole Blood | ERCC6L2 | 0.07 | 0.03 | lasso | 2 | 0.02 | 3.7e-03 | 4.04 | 5.3 | 1.5e-07 | 0.03 | 0.59 | 0.02 | FALSE |
38 | METSIM | Adipose | ANP32B | 0.05 | 0.03 | lasso | 6 | 0.02 | 1.1e-03 | -6.82 | 6.8 | 1.3e-11 | 0.01 | 0.00 | 1.00 | TRUE |
39 | METSIM | Adipose | HABP4 | 0.05 | 0.00 | bslmm | 355 | 0.01 | 1.5e-02 | 12.19 | 7.0 | 3.6e-12 | 0.03 | 0.04 | 0.49 | FALSE |
40 | NTR | Blood | C9orf3 | 0.02 | 0.02 | lasso | 1 | 0.01 | 2.5e-05 | -5.12 | -5.1 | 3.0e-07 | 0.00 | 0.98 | 0.00 | FALSE |
41 | NTR | Blood | PTCH1 | 0.04 | 0.02 | blup | 433 | 0.02 | 4.1e-08 | 13.71 | 11.2 | 5.3e-29 | 0.65 | 0.01 | 0.99 | TRUE |
42 | YFS | Blood | ANP32B | 0.03 | 0.02 | lasso | 9 | 0.02 | 1.9e-08 | -6.82 | 6.6 | 3.7e-11 | -0.02 | 0.00 | 1.00 | FALSE |
43 | YFS | Blood | HABP4 | 0.08 | 0.09 | enet | 24 | 0.11 | 5.9e-34 | 12.15 | -12.0 | 2.1e-33 | -0.04 | 0.24 | 0.76 | FALSE |
44 | YFS | Blood | PTCH1 | 0.09 | 0.05 | lasso | 8 | 0.05 | 1.2e-15 | 13.70 | 12.7 | 8.4e-37 | 0.95 | 0.10 | 0.90 | FALSE |
45 | The Cancer Genome Atlas | Bladder Urothelial Carcinoma | C9orf130 | 0.24 | 0.34 | lasso | 7 | 0.39 | 1.5e-34 | 5.53 | 6.5 | 9.8e-11 | -0.03 | 0.56 | 0.44 | FALSE |
46 | The Cancer Genome Atlas | Breast Invasive Carcinoma | C9orf102 | 0.13 | 0.00 | enet | 10 | 0.03 | 4.5e-06 | -0.59 | 5.5 | 3.1e-08 | 0.05 | 0.06 | 0.80 | FALSE |
47 | The Cancer Genome Atlas | Breast Invasive Carcinoma | C9orf130 | 0.27 | 0.41 | enet | 24 | 0.44 | 6.2e-101 | 5.53 | 6.8 | 1.2e-11 | -0.04 | 0.84 | 0.16 | FALSE |
48 | The Cancer Genome Atlas | Breast Invasive Carcinoma | CDC14B | 0.02 | 0.01 | lasso | 1 | 0.01 | 3.0e-03 | 12.39 | -12.4 | 3.0e-35 | -0.03 | 0.02 | 0.76 | FALSE |
49 | The Cancer Genome Atlas | Breast Invasive Carcinoma | HSD17B3 | 0.02 | 0.01 | enet | 7 | 0.01 | 7.3e-03 | -3.49 | 6.2 | 7.4e-10 | 0.07 | 0.19 | 0.30 | FALSE |
50 | The Cancer Genome Atlas | Cervical Squamous Cell Carcinoma | C9orf130 | 0.30 | 0.30 | blup | 73 | 0.30 | 3.6e-15 | 5.53 | 5.7 | 1.5e-08 | -0.04 | 0.38 | 0.62 | FALSE |
51 | The Cancer Genome Atlas | Colon Adenocarcinoma | C9orf130 | 0.36 | 0.38 | enet | 13 | 0.38 | 3.7e-23 | 5.53 | 6.0 | 1.7e-09 | -0.02 | 0.59 | 0.41 | FALSE |
52 | The Cancer Genome Atlas | Esophageal Carcinoma | C9orf130 | 0.39 | 0.22 | enet | 10 | 0.42 | 1.8e-14 | 6.51 | 6.2 | 5.7e-10 | -0.03 | 0.02 | 0.98 | FALSE |
53 | The Cancer Genome Atlas | Glioblastoma Multiforme | C9orf130 | 0.39 | 0.20 | blup | 73 | 0.21 | 5.8e-07 | 5.68 | 5.8 | 7.2e-09 | -0.01 | 0.04 | 0.94 | FALSE |
54 | The Cancer Genome Atlas | Glioblastoma Multiforme | CDC14B | 0.16 | 0.17 | blup | 41 | 0.19 | 2.6e-06 | 12.26 | -11.2 | 6.4e-29 | 0.00 | 0.02 | 0.96 | FALSE |
55 | The Cancer Genome Atlas | Glioblastoma Multiforme | HABP4 | 0.08 | 0.06 | blup | 44 | 0.05 | 1.6e-02 | 11.91 | -12.8 | 2.1e-37 | -0.05 | 0.03 | 0.53 | FALSE |
56 | The Cancer Genome Atlas | Head and Neck Squamous Cell Carcinoma | C9orf130 | 0.31 | 0.43 | enet | 9 | 0.45 | 9.0e-56 | 5.53 | 6.1 | 8.1e-10 | -0.06 | 0.84 | 0.16 | FALSE |
57 | The Cancer Genome Atlas | Head and Neck Squamous Cell Carcinoma | HABP4 | 0.02 | 0.02 | blup | 44 | 0.02 | 7.1e-03 | 12.26 | 12.5 | 1.1e-35 | 0.03 | 0.02 | 0.79 | FALSE |
58 | The Cancer Genome Atlas | Kidney Renal Clear Cell Carcinoma | C9orf102 | 0.07 | 0.05 | blup | 78 | 0.06 | 5.2e-07 | 6.53 | 6.0 | 1.9e-09 | 0.01 | 0.01 | 0.99 | FALSE |
59 | The Cancer Genome Atlas | Kidney Renal Clear Cell Carcinoma | C9orf130 | 0.36 | 0.43 | lasso | 6 | 0.52 | 6.8e-69 | 6.14 | 6.7 | 2.3e-11 | 0.01 | 0.13 | 0.87 | FALSE |
60 | The Cancer Genome Atlas | Kidney Renal Clear Cell Carcinoma | CDC14B | 0.03 | 0.02 | blup | 42 | 0.02 | 2.1e-03 | 12.26 | -12.7 | 1.0e-36 | -0.03 | 0.02 | 0.79 | FALSE |
61 | The Cancer Genome Atlas | Kidney Renal Clear Cell Carcinoma | FAM22F | 0.03 | 0.02 | blup | 26 | 0.01 | 2.8e-02 | -5.87 | -6.2 | 4.2e-10 | 0.01 | 0.00 | 0.88 | FALSE |
62 | The Cancer Genome Atlas | Kidney Renal Clear Cell Carcinoma | HSD17B3 | 0.03 | 0.00 | blup | 98 | 0.01 | 1.7e-02 | -3.49 | 6.2 | 4.0e-10 | 0.09 | 0.06 | 0.04 | FALSE |
63 | The Cancer Genome Atlas | Kidney Renal Clear Cell Carcinoma | PTCH1 | 0.04 | 0.00 | blup | 56 | 0.02 | 1.6e-03 | 13.70 | 7.8 | 8.2e-15 | 0.73 | 0.02 | 0.52 | FALSE |
64 | The Cancer Genome Atlas | Kidney Renal Papillary Cell Carcinoma | C9orf130 | 0.34 | 0.27 | blup | 73 | 0.36 | 7.6e-22 | 5.68 | 6.1 | 1.2e-09 | -0.07 | 0.59 | 0.41 | FALSE |
65 | The Cancer Genome Atlas | Kidney Renal Papillary Cell Carcinoma | HIATL1 | 0.07 | 0.02 | blup | 44 | 0.04 | 2.3e-03 | 5.07 | 6.2 | 4.7e-10 | -0.02 | 0.11 | 0.08 | FALSE |
66 | The Cancer Genome Atlas | Brain Lower Grade Glioma | C9orf130 | 0.29 | 0.49 | lasso | 7 | 0.51 | 7.5e-67 | 5.53 | 5.7 | 9.7e-09 | -0.05 | 0.84 | 0.16 | FALSE |
67 | The Cancer Genome Atlas | Brain Lower Grade Glioma | CDC14B | 0.05 | 0.06 | lasso | 5 | 0.06 | 6.5e-07 | 12.31 | -11.4 | 4.5e-30 | -0.02 | 0.03 | 0.97 | FALSE |
68 | The Cancer Genome Atlas | Brain Lower Grade Glioma | HABP4 | 0.05 | 0.08 | lasso | 5 | 0.08 | 6.9e-09 | 12.10 | -12.3 | 1.2e-34 | -0.04 | 0.04 | 0.96 | FALSE |
69 | The Cancer Genome Atlas | Liver Hepatocellular Carcinoma | C9orf130 | 0.32 | 0.31 | blup | 73 | 0.32 | 9.9e-16 | 6.14 | 6.7 | 1.8e-11 | 0.00 | 0.06 | 0.94 | FALSE |
70 | The Cancer Genome Atlas | Lung Adenocarcinoma | C9orf130 | 0.43 | 0.47 | lasso | 6 | 0.52 | 5.1e-71 | 5.53 | 6.5 | 8.2e-11 | -0.03 | 0.83 | 0.17 | FALSE |
71 | The Cancer Genome Atlas | Lung Squamous Cell Carcinoma | C9orf130 | 0.27 | 0.33 | lasso | 4 | 0.36 | 1.9e-42 | 5.53 | 6.5 | 8.9e-11 | -0.04 | 0.74 | 0.26 | FALSE |
72 | The Cancer Genome Atlas | Lung Squamous Cell Carcinoma | HIATL1 | 0.04 | 0.01 | blup | 44 | 0.03 | 8.8e-05 | -3.24 | 5.7 | 1.1e-08 | -0.05 | 0.22 | 0.12 | FALSE |
73 | The Cancer Genome Atlas | Ovarian Serous Cystadenocarcinoma | C9orf130 | 0.21 | 0.25 | lasso | 8 | 0.29 | 7.6e-20 | 5.53 | 6.1 | 1.2e-09 | -0.04 | 0.73 | 0.27 | FALSE |
74 | The Cancer Genome Atlas | Pancreatic Adenocarcinoma | C9orf130 | 0.49 | 0.46 | enet | 13 | 0.52 | 2.8e-25 | 5.68 | 6.2 | 7.1e-10 | -0.03 | 0.11 | 0.89 | FALSE |
75 | The Cancer Genome Atlas | Pheochromocytoma and Paraganglioma | C9orf130 | 0.43 | 0.33 | blup | 73 | 0.34 | 3.7e-14 | 6.14 | 6.3 | 2.9e-10 | -0.03 | 0.20 | 0.80 | FALSE |
76 | The Cancer Genome Atlas | Prostate Adenocarcinoma | C9orf102 | 0.06 | 0.02 | blup | 78 | 0.03 | 2.3e-04 | 6.51 | 5.8 | 5.3e-09 | 0.00 | 0.01 | 0.98 | FALSE |
77 | The Cancer Genome Atlas | Prostate Adenocarcinoma | C9orf130 | 0.37 | 0.58 | enet | 17 | 0.64 | 9.7e-88 | 5.53 | 6.3 | 3.7e-10 | -0.03 | 0.84 | 0.16 | FALSE |
78 | The Cancer Genome Atlas | Prostate Adenocarcinoma | HIATL1 | 0.18 | 0.05 | blup | 44 | 0.12 | 3.9e-12 | 4.35 | 5.8 | 4.8e-09 | 0.05 | 0.98 | 0.00 | FALSE |
79 | The Cancer Genome Atlas | Prostate Adenocarcinoma | PTCH1 | 0.02 | 0.01 | blup | 54 | 0.02 | 1.1e-03 | 13.17 | -10.8 | 2.6e-27 | -0.19 | 0.06 | 0.04 | FALSE |
80 | The Cancer Genome Atlas | Rectum Adenocarcinoma | C9orf130 | 0.28 | 0.16 | blup | 73 | 0.18 | 4.6e-05 | 6.47 | 5.6 | 2.5e-08 | -0.01 | 0.02 | 0.93 | FALSE |
81 | The Cancer Genome Atlas | Soft Tissue Sarcoma | C9orf130 | 0.18 | 0.15 | blup | 73 | 0.17 | 2.6e-10 | 6.14 | 6.1 | 1.3e-09 | 0.01 | 0.07 | 0.93 | FALSE |
82 | The Cancer Genome Atlas | Skin Cutaneous Melanoma | C9orf130 | 0.26 | 0.10 | lasso | 2 | 0.17 | 2.4e-05 | 6.14 | 6.8 | 1.0e-11 | 0.02 | 0.04 | 0.80 | FALSE |
83 | The Cancer Genome Atlas | Stomach Adenocarcinoma | C9orf130 | 0.31 | 0.28 | blup | 73 | 0.37 | 7.7e-28 | 5.53 | 6.8 | 1.5e-11 | -0.05 | 0.03 | 0.97 | FALSE |
84 | The Cancer Genome Atlas | Stomach Adenocarcinoma | CDC14B | 0.08 | 0.02 | blup | 41 | 0.04 | 1.0e-03 | 10.10 | -12.9 | 2.4e-38 | -0.05 | 0.02 | 0.70 | TRUE |
85 | The Cancer Genome Atlas | Stomach Adenocarcinoma | HIATL1 | 0.04 | 0.01 | blup | 44 | 0.02 | 2.1e-02 | 5.05 | 6.6 | 3.1e-11 | -0.03 | 0.02 | 0.17 | FALSE |
86 | The Cancer Genome Atlas | Testicular Germ Cell Tumors | C9orf130 | 0.36 | 0.35 | lasso | 10 | 0.41 | 1.2e-15 | 6.46 | 6.6 | 3.3e-11 | 0.00 | 0.02 | 0.98 | FALSE |
87 | The Cancer Genome Atlas | Testicular Germ Cell Tumors | SLC35D2 | 0.18 | 0.04 | blup | 74 | 0.07 | 1.8e-03 | -6.64 | -7.7 | 2.0e-14 | -0.07 | 0.03 | 0.12 | FALSE |
88 | The Cancer Genome Atlas | Thyroid Carcinoma | C9orf130 | 0.56 | 0.60 | enet | 14 | 0.68 | 1.2e-89 | 5.53 | 6.4 | 1.2e-10 | -0.02 | 0.83 | 0.17 | FALSE |
89 | The Cancer Genome Atlas | Thyroid Carcinoma | C9orf3 | 0.03 | 0.02 | lasso | 4 | 0.02 | 4.0e-03 | -4.92 | -5.8 | 6.1e-09 | -0.05 | 0.26 | 0.10 | FALSE |
90 | The Cancer Genome Atlas | Thyroid Carcinoma | CDC14B | 0.05 | 0.07 | blup | 42 | 0.08 | 4.8e-08 | 12.40 | -12.1 | 8.3e-34 | -0.02 | 0.02 | 0.98 | FALSE |
91 | The Cancer Genome Atlas | Uterine Corpus Endometrial Carcinoma | C9orf130 | 0.18 | 0.01 | blup | 73 | 0.03 | 5.3e-02 | 6.50 | 5.9 | 3.4e-09 | -0.03 | 0.02 | 0.57 | FALSE |